Post by
subaru1i on Nov 15, 2023 7:17am
I think of some of you missed the China point...
China is researching cannabinoid based pharmceutical API's and the article from May 2023 that discussed their research work including an alternative to Epidiolex for epilepsy is proof that this pharma "lollipop" has expanded globally beyond what many here appreciate. That research paper dated May 2023 may also reflect China's efforts now to accelerate those studies and do a little catch up when compared to the over 20 strong clinical trials, many in late stage, that LABS is conducting with a global pharmaceutical partner. As well as the paper on CBCV and THCV it also documented the acid form of cannabinoids and that process has global patents on it that have already been licensed for commercializtion.
We now lay that upon the comments and the deal made between Pfizer and the People's Republic of China w.r.t. to supporting and providing better health care for their people.
ps: Congratulations on that 7nm smart phone chip. Uncle Sam has his shorts in a knot now but carry on with the Tokamak Russian design for a fusion reactor. Do not give up and the entire world will praise your efforts for developing a clean an inexhaustible source of energy with the capability to turn all the global desserts from dry sand into beautiful lush farm land and offset the effects of climate change. I hope Uncle Sam enjoys importing beef as well.
Comment by
TreborTheGreat on Nov 15, 2023 11:14am
Market is maybe big globally. Got it.